Proteomics-Based Strategy to Identify Biomarkers and Pharmacological Targets in Leukemias with t(4;11) Translocations-Reference-Cited by-同舟云学术

Proteomics-Based Strategy to Identify Biomarkers and Pharmacological Targets in Leukemias with t(4;11) Translocations

Published:2006-08-18 Issue:10 Volume:5 Page:2743-2753
ISSN:1535-3893
Container-title:Journal of Proteome Research
language:en
Short-container-title:J. Proteome Res.

Author:

Yocum Anastasia K.¹,Busch Christine M.¹,Felix Carolyn A.¹,Blair Ian A.¹

Affiliation:

1. Center for Cancer Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104-6160, and Division of Oncology, The Children's Hospital of Philadelphia, Department of Pediatrics, University of Pennsylvania School of Medicine, Pennsylvania 19104-4318

Publisher

American Chemical Society (ACS)

Subject

General Chemistry,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/pr060235v

Reference48 articles.

1. When epigenetics kills: MLL fusion proteins in leukemia

3. Human Genome and Diseases:¶Double-strand breaks and translocations in cancer

4. Differentiation inhibitory factor nm23 as a new prognostic factor in acute monocytic leukemia

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Importance of targeted therapies in acute myeloid leukemia;Translational Biotechnology;2021

2. Quantitative Age-specific Variability of Plasma Proteins in Healthy Neonates, Children and Adults;Molecular & Cellular Proteomics;2017-05

3. Advancement of mass spectrometry-based proteomics technologies to explore triple negative breast cancer;Molecular BioSystems;2017

4. Serum Protein Profiling of Adults and Children With Crohn Disease;Journal of Pediatric Gastroenterology & Nutrition;2015-01

5. Proteomics approaches for myeloid leukemia drug discovery;Expert Opinion on Drug Discovery;2012-09-13